EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 4.0

Unraveling the Role of WDR91 : Case Report of a Previously Unrecognized Clinical Entity

Nikolaos M Marinakis iD, Afrodite Kampouraki, Danai Veltra iD, Faidon-Nikolaos Tilemis, Maria Vasilopoulou, Aikaterini Dokou, Elissavet Georgiadou, Euthalia Karavergou, Maria Christolouka, Alexis Alexopoulos, Dimitra Kirillidi, Maria Goudesidou und 3 weitere

Clinical Genetics · 2026-01 · 109 (1) · 176-180

DOI: 10.1111/cge.70012 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Clinical Genetics, online erschienen am 23.06.2025. Verfasst von Nikolaos M Marinakis und 14 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Medical Genetics, Medical School, St. Sophia's Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece. Hauptthemen laut MEDLINE: Carrier Proteins, Genetic Predisposition to Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

WDR91, a WD40 repeat domain‐containing protein, is a key regulator of endosomal trafficking, lysosomal function, and autophagy. It acts as a Rab7 effector, forming a complex with WDR81 to modulate phosphatidylinositol 3‐kinase (PI3K) activity, endosomal maturation, and lysosome homeostasis. Loss‐of‐function variants in WDR91 are considered related to endosomal accumulation, impaired cargo degradation, and neurodegeneration. In this report, an autosomal recessive neurodevelopmental disorder is proposed, associated with WDR91 loss‐of‐function in a consanguineous family. The patient presented with severe microcephaly, dysmorphic features, and organomegaly, along with early onset psychomotor delay, hypotonia, sensorineural hearing impairment, and visual impairment. Whole‐exome sequencing (WES) identified a homozygous splice site variant, NM_014149.4:c.1395+1G>A, predicted to disrupt the donor site and classified as likely pathogenic (PVS1, PM2). The variant was absent from population databases and our internal in‐house cohort. Functional analysis supports a pathogenic role for the variant. WDR91 deficiency results in neuronal loss, cortical thinning, and impaired brain development, as evidenced in Wdr91 knockout models. Our study expands the clinical and genetic spectrum of WDR91‐related disorders and highlights the need for further investigations to elucidate the precise molecular mechanisms underlying WDR91‐associated pathogenesis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carrier ProteinsGenetic Predisposition to DiseaseHumansMaleFemalePedigreeExome SequencingMicrocephalyPhenotypeMutationChild, PreschoolChildConsanguinity

Stichwörter der Autor:innen

WDR91brain malformationsloss of functionneurodevelopmental disorder

Substanzen

Carrier Proteins

Autor:innen und Institutionen

  • Laboratory of Medical Genetics, Medical School, St. Sophia's Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • Research University Institute for the Study and Prevention of Genetic and Malignant Disease of Childhood, St. Sophia's Children's Hospital, National and Kapodistrian University of Athens, Athens, Greece.
  • B' Pediatric Clinic, Agia Sofia Children's Hospital, Athens, Greece.
  • First Department of Paediatrics, National and Kapodistrian University of Athens, 'Aghia Sophia' Children's Hospital, Athens, Greece.
  • Special Unit of Dermatology, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, Agia Sofia Children's Hospital, Athens, Greece.
  • Neonatal Intensive Care Unit (NICU) of the Department of Pediatrics, University of Thessaly, University General Hospital of Larissa, Larissa, Greece.

ORCID-Profile: Nikolaos M Marinakis, Danai Veltra, Christalena Sofocleous

Zitieren

APA

Marinakis, N. M., Kampouraki, A., Veltra, D., Tilemis, F. N., Vasilopoulou, M., Dokou, A., Georgiadou, E., Karavergou, E., Christolouka, M., Alexopoulos, A., Kirillidi, D., Goudesidou, M., Kosma, K., Sofocleous, C., & Makrythanasis, P. (2026). Unraveling the Role of WDR91 : Case Report of a Previously Unrecognized Clinical Entity. Clinical Genetics, 109(1), 176-180. https://doi.org/10.1111/cge.70012

Vancouver

Marinakis NM, Kampouraki A, Veltra D, Tilemis FN, Vasilopoulou M, Dokou A, et al. Unraveling the Role of WDR91 : Case Report of a Previously Unrecognized Clinical Entity. Clinical Genetics. 2026;109(1):176-180. doi:10.1111/cge.70012

BibTeX
@article{Marinakis2026,
  author = {Marinakis, Nikolaos M and Kampouraki, Afrodite and Veltra, Danai and Tilemis, Faidon-Nikolaos and Vasilopoulou, Maria and Dokou, Aikaterini and Georgiadou, Elissavet and Karavergou, Euthalia and Christolouka, Maria and Alexopoulos, Alexis and Kirillidi, Dimitra and Goudesidou, Maria and Kosma, Konstantina and Sofocleous, Christalena and Makrythanasis, Periklis},
  title = {Unraveling the Role of WDR91 : Case Report of a Previously Unrecognized Clinical Entity},
  journal = {Clinical Genetics},
  year = {2026},
  volume = {109},
  number = {1},
  pages = {176--180},
  doi = {10.1111/cge.70012}
}
Kostenlos starten →